NeuroSense Therapeutics Ltd. (NRSNW) Operating cash flow 2021–2025
NeuroSense Therapeutics Ltd. (NRSNW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.7MFY2025 · since FY2021: -$1.5M → -$7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.7M | +24.3% |
| FY2024 | -$10.1M | -21.3% |
| FY2023 | -$8.4M | -9.7% |
| FY2022 | -$7.6M | -394.9% |
| FY2021 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice